Lindbrook Capital’s Twist Bioscience TWST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
$2.55K Buy
65
+16
+33% +$721 ﹤0.01% 2210
2024
Q4
$2.28K Buy
49
+3
+7% +$136 ﹤0.01% 2273
2024
Q3
$2.08K Sell
46
-30
-39% -$1.43K ﹤0.01% 2331
2024
Q2
$3.75K Sell
76
-11
-13% -$449 ﹤0.01% 2126
2024
Q1
$2.98K Buy
87
+48
+123% +$1.73K ﹤0.01% 2101
2023
Q4
$1.44K Sell
39
-10
-20% -$231 ﹤0.01% 2372
2023
Q3
$993 Sell
49
-23
-32% -$505 ﹤0.01% 2360
2023
Q2
$1.47K Sell
72
-19
-21% -$285 ﹤0.01% 2266
2023
Q1
$1.37K Buy
91
+84
+1,200% +$1.86K ﹤0.01% 2379
2022
Q4
$167 Sell
7
-27
-79% -$783 ﹤0.01% 2758
2022
Q3
$1K Buy
34
+27
+386% +$1.15K ﹤0.01% 2510
2022
Q2
$0 Sell
7
-30
-81% -$1.06K ﹤0.01% 2776
2022
Q1
$2K Sell
37
-70
-65% -$3.88K ﹤0.01% 2098
2021
Q4
$8K Buy
107
+62
+138% +$6.36K ﹤0.01% 1375
2021
Q3
$5K Buy
45
+8
+22% +$916 ﹤0.01% 1267
2021
Q2
$5K Sell
37
-88
-70% -$10.2K ﹤0.01% 1313
2021
Q1
$15K Buy
125
+88
+238% +$13.4K ﹤0.01% 858
2020
Q4
$5K Hold
37
﹤0.01% 1211
2020
Q3
$3K Hold
37
﹤0.01% 1317
2020
Q2
$2K Buy
+37
New +$1.33K ﹤0.01% 1450

Other funds holding TWST

Lindbrook Capital's TWST Position: Q1 2025 in Review

Lindbrook Capital increased its Twist Bioscience (TWST) stake by 33% in Q1 2025, buying an estimated $721 and bringing the position to 65 shares worth $2.55K. The position accounts for ﹤0.01% of the portfolio, ranked #2210.

Lindbrook Capital first reported a position in TWST in Q2 2020 and has held it in 20 quarters since. The position peaked at $15K in Q1 2021. 263 funds tracked by Wall St. Rank hold TWST as of Q1 2025.

  • Lindbrook Capital held 65 shares of Twist Bioscience worth $2.55K as of Q1 2025.
  • Lindbrook Capital bought 16 Twist Bioscience shares in Q1 2025, an estimated $721.
  • Twist Bioscience made up ﹤0.01% of Lindbrook Capital's portfolio in Q1 2025, its #2210 holding.
  • Lindbrook Capital first reported a position in Twist Bioscience in Q2 2020 and has held it in 20 quarters since.
  • Lindbrook Capital's Twist Bioscience position peaked at $15K in Q1 2021.
  • 263 funds tracked by Wall St. Rank held Twist Bioscience as of Q1 2025.

Based on Lindbrook Capital's 13F filing for Q1 2025, filed 5 May 2025.